Australia
Australia E-Pharmacy Market Industry Trends and Forecast to 2034: Segmented by (Product, Platform, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034
Australia · 2024–2034 · estimates
Values shown here are estimates. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.
China at $11.31 Bn.
India at 18.1% a year.Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.
$5.01 Bn total, 2026–2034
| Year | Market size | Change that year | Since 2025 |
|---|---|---|---|
| 2024 (estimate) | $1.47 Bn | — | — |
| 2025 (base) | $1.71 Bn | +$241.6 Mn | — |
| 2026 (forecast) | $2.00 Bn | +$281.2 Mn | +16.4% |
| 2027 (forecast) | $2.32 Bn | +$327.4 Mn | +35.5% |
| 2028 (forecast) | $2.70 Bn | +$381.1 Mn | +57.7% |
| 2029 (forecast) | $3.15 Bn | +$443.5 Mn | +83.6% |
| 2030 (forecast) | $3.66 Bn | +$516.3 Mn | +113.7% |
| 2031 (forecast) | $4.27 Bn | +$601.0 Mn | +148.7% |
| 2032 (forecast) | $4.96 Bn | +$699.5 Mn | +189.5% |
| 2033 (forecast) | $5.78 Bn | +$814.2 Mn | +237% |
| 2034 (forecast) | $6.73 Bn | +$947.8 Mn | +292.3% |
Estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.
US
$44.23 Bn
China
$11.31 Bn
Canada
$9.70 Bn
Japan
$8.24 Bn
Germany
$4.76 Bn
UK
$3.36 Bn
Brazil
$3.26 Bn
France
$2.87 Bn
Spain
$2.64 Bn
Italy
$2.54 Bn
India
$2.49 Bn
Ecuador
$2.21 Bn
Saudi Arabia
$2.09 Bn
Mexico
$1.96 Bn
Australia (this report)
$1.71 Bn
Russia
$1.15 Bn
New Zealand
$1.12 Bn
South Africa
$746.5 Mn
UAE
$696.6 Mn
Egypt
$351.1 Mn
Philippines
$295.3 Mn
Malaysia
$203.3 Mn
Hong Kong
$202.1 Mn
Thailand
$171.3 Mn
Singapore
$158.4 Mn
Kenya
$96.1 Mn
E-pharmacies sell medicines and health products online and deliver them to the home.
Key segments of the e-Pharmacy market include product (Prescription Medicines, OTC Products and Personal Care) and platform (App-Based and Web-Based).
Rising incomes, fast-growing private hospital chains, medical tourism, government health reforms and a young, digital-first population are driving the e-Pharmacy market.
Public-private partnerships, digital health and growing middle classes in Asia, the Middle East, Africa and Latin America give the e-Pharmacy market strong room to grow.
Uneven quality standards, limited insurance coverage, high out-of-pocket costs and regulatory differences between countries hold back the e-Pharmacy market.
The e-Pharmacy market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.
Rules on software as a medical device, data privacy (such as HIPAA and GDPR) and telehealth reimbursement shape the e-Pharmacy market. Government digital health programs in Australia are speeding up adoption.
What doctors and scientists are doing in E-Pharmacy right now, from free public sources.
Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov, World Bank. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.
From our blog
Australia
Australia
Australia
Australia
Australia
Australia
Pharmaceuticals · Australia
Pharmaceuticals · Australia
Medical Devices · Australia
Healthcare Services · Australia
Pharmaceuticals · Australia
Healthcare Services · Australia